Clinical Trial Update: An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With Chronic Hepatitis B Who Have Failed Antiviral Treatment With Nucleoside (Nucleotide) Analogues

View source ↗

Summary

An observational study evaluating Pegasys (peginterferon alfa-2a) in patients with chronic hepatitis B who failed nucleoside analogue therapy has been terminate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Pegasys (pegylated interferon alfa-2a)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Hepatitis B, Chronic | Status: TERMINATED